E. Bradatan , A.-K. Correard , D. Caimmi , A. Nemni , P. Biermé , C. Favre-Metz , D. Sabouraud , F. Morel Codreanu , E. Michaud , F. Villard-Truc , C. Braun
{"title":"Mise au point sur l’immunothérapie multi-aliment","authors":"E. Bradatan , A.-K. Correard , D. Caimmi , A. Nemni , P. Biermé , C. Favre-Metz , D. Sabouraud , F. Morel Codreanu , E. Michaud , F. Villard-Truc , C. Braun","doi":"10.1016/j.reval.2024.104163","DOIUrl":null,"url":null,"abstract":"<div><div>Multi-food oral immunotherapy (OIT) represents a potential avenue for the simultaneous management of multiple food allergies. It encompasses the ingestion of a range of allergens on a daily basis, with doses increasing progressively until a maintenance dose is reached. Multi-food OIT must follow a patient-centered approach. As with single-food OIT, multi-food OIT is responsible for mainly mild to moderate allergic reactions, which can be readily managed or prevented by conventional anti-allergy medication. However, the available literature suggests that multi-food OIT is as well tolerated as single-food OIT. The need for a technical platform and expertise continues to impede the accessibility of multi-food OIT. Low-dose OIT may be a solution to reduce allergic side effects and facilitating access to office-based multi-food OIT.</div></div>","PeriodicalId":49130,"journal":{"name":"Revue Francaise d Allergologie","volume":"65 1","pages":"Article 104163"},"PeriodicalIF":0.3000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue Francaise d Allergologie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877032024003841","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Multi-food oral immunotherapy (OIT) represents a potential avenue for the simultaneous management of multiple food allergies. It encompasses the ingestion of a range of allergens on a daily basis, with doses increasing progressively until a maintenance dose is reached. Multi-food OIT must follow a patient-centered approach. As with single-food OIT, multi-food OIT is responsible for mainly mild to moderate allergic reactions, which can be readily managed or prevented by conventional anti-allergy medication. However, the available literature suggests that multi-food OIT is as well tolerated as single-food OIT. The need for a technical platform and expertise continues to impede the accessibility of multi-food OIT. Low-dose OIT may be a solution to reduce allergic side effects and facilitating access to office-based multi-food OIT.
期刊介绍：
La Revue Française d''Allergologie : un véritable forum pour faire connaître des travaux originaux et permettre la diffusion de l''information auprès de toutes les spécialités concernées par les pathologies allergiques. La Revue Française d''Allergologie (8 numéros par an) est au carrefour de nombreuses spécialités - dermatologie, pédiatrie, ORL, pneumologie, ophtalmologie, médecine interne - qui, toutes, ont à traiter des maladies allergiques. Les symptômes des allergies fondés sur des mécanismes communs sont le plus souvent associés et se succèdent chez un même patient. En forte progression depuis 20 ans, les maladies allergiques sont dans l''attente de perfectionnements et d''avancées thérapeutiques qui permettront aux nombreux patients qui en sont atteints de mieux vivre avec leurs allergies. La Revue Française d''Allergologie se veut donc un véritable forum de discussions et d''échanges entre tous les spécialistes confrontés aux pathologies
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
